Woodline Partners’s Ventyx Biosciences VTYX Stock Holding History

Woodline Partners’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-45,826	Closed	-$143K	–	1128
2025 Q3	$143K	Buy	+45,826	New	+$121K	﹤0.01%	866
2025 Q2	–	Sell	-208,656	Closed	-$240K	–	1059
2025 Q1	$240K	Sell	208,656 -4,584	-2%	-$7.87K	﹤0.01%	869
2024 Q4	$467K	Buy	+213,240	New	+$483K	﹤0.01%	843
2024 Q3	–	Sell	-379,175	Closed	-$876K	–	713
2024 Q2	$876K	Buy	+379,175	New	+$1.58M	0.01%	470
2023 Q4	–	Sell	-203,783	Closed	-$7.08M	–	667
2023 Q3	$7.08M	Buy	203,783 +53,783	+36%	+$1.86M	0.08%	261
2023 Q2	$4.92M	Buy	150,000 +23,286	+18%	+$803K	0.06%	295
2023 Q1	$4.24M	Buy	126,714 +6,701	+6%	+$261K	0.06%	317
2022 Q4	$3.94M	Sell	120,013 -8,650	-7%	-$256K	0.05%	352
2022 Q3	$4.49M	Buy	128,663 +8,663	+7%	+$192K	0.06%	314
2022 Q2	$1.47M	Hold	120,000	–	–	0.02%	480
2022 Q1	$1.63M	Hold	120,000	–	–	0.03%	408
2021 Q4	$2.38M	Buy	+120,000	New	+$2.27M	0.03%	396

Other funds holding VTYX

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Woodline Partners's VTYX Position: Q4 2025 in Review

Woodline Partners sold out of Ventyx Biosciences (VTYX) in Q4 2025, closing a stake of 45,826 shares — an estimated $143K sold.

Woodline Partners first reported a position in VTYX in Q4 2021 and held it in 12 quarters. The position peaked at $7.08M in Q3 2023. 139 funds tracked by Wall St. Rank hold VTYX as of Q4 2025.

Woodline Partners reported no remaining Ventyx Biosciences position as of Q4 2025 after selling out during the quarter.
Woodline Partners sold 45,826 Ventyx Biosciences shares in Q4 2025, an estimated $143K.
Woodline Partners first reported a position in Ventyx Biosciences in Q4 2021 and held it in 12 quarters.
Woodline Partners's Ventyx Biosciences position peaked at $7.08M in Q3 2023.
139 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q4 2025.

Based on Woodline Partners's 13F filing for Q4 2025, filed 17 Feb 2026.